EmbracePlus SpO2 Accuracy Validation

Status Completed

Clinical Trial Summary

The aim of this study is to test the accuracy of EmbracePlus computed SpO2 during mild, moderate and severe hypoxia (a lower-than-normal concentration of oxygen in arterial blood); ie, a range of arterial HbO2 saturations from 100 to down to 70%. This is done by comparing the reading of the the subject device during brief, steady state hypoxia with a gold-standard measurement of blood oxyhemoglobin (hemoglobin carrying oxygen) saturation, that is arterial blood sample processed in a laboratory.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Oximetry

Clinical Trial Details

NCT number	NCT04964609
Study type	Interventional
Source	Empatica, Inc.
Contact
Status	Completed
Phase	N/A
Start date	June 16, 2021
Completion date	November 21, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01530360` - Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants	Phase 1
Completed	`NCT03710980` - Accuracy of Pulse Oximeters With Profound Hypoxia
Recruiting	`NCT06015204` - Assessment of the C8 Dermatomal Block With Photoplethysmographic Amplitude After Interscalene Brachial Plexus Block	N/A
Completed	`NCT03250065` - The Sensing ET Tube	N/A
Completed	`NCT04380389` - Accuracy of ScanWatch Pulse Oximeter With Profound Hypoxia	N/A
Completed	`NCT04562584` - Pulse Oximeter Hypoxia	N/A
Recruiting	`NCT04587921` - Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19	N/A
Completed	`NCT03710993` - Accuracy Assessment of Beddr Oximeter
Completed	`NCT04324385` - Accuracy of Pulse Oximeters With Profound Hypoxia
Completed	`NCT03534271` - The Accuracy of Smartphone Pulse Oximetry in Patients Visiting an Outpatient Pulmonary Function Lab for a 6-Minute Walk Test